Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

46.76
-0.3200-0.68%
Post-market: 46.760.00000.00%17:05 EDT
Volume:2.23M
Turnover:104.76M
Market Cap:112.50B
PE:12.44
High:47.59
Open:47.57
Low:46.64
Close:47.08
52wk High:55.73
52wk Low:43.32
Shares:2.41B
Float Shares:2.20B
Volume Ratio:0.88
T/O Rate:0.10%
Dividend:2.27
Dividend Rate:4.86%
EPS(TTM):3.76
EPS(LYR):3.76
ROE:6.66%
ROA:4.65%
PB:1.34
PE(LYR):12.44

Loading ...

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

GlobeNewswire
·
Dec 23, 2025

Merck (MRK.US), Bristol-Myers Squibb (BMY.US), and Other Pharma Giants Agree to Lower U.S. Drug Prices in Exchange for Tariff Exemptions and Policy Support

Stock News
·
Dec 20, 2025

Sanofi Reports Deal with US Government to Lower Medicine Costs

MT Newswires Live
·
Dec 20, 2025

Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies

MT Newswires Live
·
Dec 20, 2025

Deals Are With Amgen, Bristol Myers Squibb, Roche’s Genentech, Gilead, GSK, Merck, Novartis, Sanofi and Boehringer Ingelheim -U.S. Official

THOMSON REUTERS
·
Dec 20, 2025

at Least Seven Drug Companies Are Set to Announce Price Cuts With Trump at White House on Friday, Including Glaxosmithkline, Merck and Sanofi - Wapo

THOMSON REUTERS
·
Dec 20, 2025

Sanofi Needs to Show Progress on Pipeline to Rebuild Investor Trust -- Market Talk

Dow Jones
·
Dec 19, 2025

Sanofi SA (SNY.US) Announces Approval of Second-Generation Cardiac Myosin Inhibitor in China

Stock News
·
Dec 17, 2025

Sanofi Says Efdoralprin Alfa Gets Orphan Drug Designation in EU

MT Newswires Live
·
Dec 17, 2025

Koru Medical Systems Names Eric Schiller as CTO

MT Newswires Live
·
Dec 17, 2025

Sanofi, Dren Bio Collaborate on Next-Gen B-Cell Therapy for Autoimmune Diseases

MT Newswires Live
·
Dec 15, 2025

Sanofi's Multiple Sclerosis Drug Faces Trial And Regulatory Setbacks

Benzinga_recent_news
·
Dec 15, 2025

Sanofi Says Primary Progressive Multiple Sclerosis Drug did not Meet Main Goal in a Phase 3 Trial

MT Newswires Live
·
Dec 15, 2025

Stocks to Watch Monday: iRobot, EchoStar, Rocket Lab, Alibaba -- WSJ

Dow Jones
·
Dec 15, 2025

Sanofi’s MS Drug Takes Double Hit With FDA Delay, Trial Failure

Tiger Newspress
·
Dec 15, 2025

Sanofi Says China Approved 2 Rare Blood Disorder Therapies

MT Newswires Live
·
Dec 11, 2025

Dow Jones Top Company Headlines at 3 AM ET: Sanofi's Bleeding-Disorder Treatments Get Approval in China | Broadcom ...

Dow Jones
·
Dec 11, 2025

EXCLUSIVE-US FDA launches fresh safety scrutiny of approved RSV therapies for infants

Reuters
·
Dec 09, 2025

Exclusive-U.S. FDA Officials Inform Merck, Sanofi and AstraZeneca Rsv Antibody Therapies Would Receive Fresh Safety Scrutiny -Sources Familiar With the Situation

THOMSON REUTERS
·
Dec 09, 2025

European Equities Traded in the US as ADRs Little Changed in Monday Trading

MT Newswires Live
·
Dec 09, 2025